Rubeshan Perumal

Also affiliated with Global Virus Network, Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial”.

INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial

BMJ Open(2022)10.1136/bmjopen-2022-067765

N/A

0.484DataRank · unranked

7 citations

Kelly E. Dooley, Kogieleum Naidoo, Nesri Padayatchi, Nonhlanhla Yende‐Zuma, Rubeshan Perumal +4 more

Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial

Trials(2023)10.1186/s13063-023-07520-9

N/A

0.405DataRank · unranked

7 citations

Rubeshan Perumal, Allison Wolf, Mbali Zulu, Kevin Guzman, Boitumelo Seepamore +12 more

Fixed-dose combination bictegravir–emtricitabine–tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial

The Lancet HIV(2025)10.1016/s2352-3018(25)00200-0

N/A

0.165DataRank · unranked

2 citations

Kogieleum Naidoo, Marothi Letsoalo, Roeland E. Wasmann, Gillian Dorse, Rubeshan Perumal +33 more

A position statement and practical guide to the use of particulate filtering facepiece (N95, FFP2, or equivalent) respirators for South African health care workers exposed to respiratory pathogens including M. tuberculosis and SARS-CoV-2

AfricArXiv (OSF Preprints)(2021)10.31730/osf.io/zp9wn

N/A

0.104DataRank · unranked

1 citations

Salome Charalambous, Aaron S Karat, Arne von Delft, Umesh Lalloo, Richard N. van Zyl-Smit +26 more

Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes

Clinical Infectious Diseases(2022)10.1093/cid/ciac185

N/A

0DataRank · unranked

16 citations

Mikaila C. Moodley, Razia Hassan-Moosa, Navisha Dookie, Nonhlanhla Yende‐Zuma, Rubeshan Perumal +5 more

Advances in tuberculosis control during the past decade

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00090-5

N/A

0DataRank · unranked

20 citations

Rubeshan Perumal, Kogieleum Naidoo

A position statement and practical guide to the use of particulate filtering facepiece respirators (N95, FFP2, or equivalent) for South African health workers exposed to respiratory pathogens including Mycobacterium tuberculosis and SARS-CoV-2

African Journal of Thoracic and Critical Care Medicine(2021)10.7196/ajtccm.2021.v111i4.173

N/A

0DataRank · unranked

2 citations

Salome Charalambous, A S Kharat, Arne von Delft, Richard N. van Zyl-Smit, Rubeshan Perumal +25 more

Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: an individual isolate meta-analysis

medRxiv(2023)10.1101/2023.05.04.23289023

N/A

0DataRank · unranked

2 citations

Neda Bionghi, Matthew J. Cummings, Rubeshan Perumal, Madeleine Hopson, Shamim Al Jubaer +5 more

Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): Study protocol for an adaptive randomized controlled trial

Research Square(2023)10.21203/rs.3.rs-2841179/v1

N/A

0DataRank · unranked

0 citations

Rubeshan Perumal, Allison Wolf, Mbali Zulu, Kevin Guzman, Boitumelo Seepamore +12 more

Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysis

The Lancet Microbe(2024)10.1016/s2666-5247(23)00317-8

N/A

0DataRank · unranked

14 citations

Neda Bionghi, Matthew J. Cummings, Rubeshan Perumal, Madeleine Hopson, Shamim Al Jubaer +6 more

Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae438

N/A

0DataRank · unranked

9 citations

Amy K. Rourke, Emmanuel Asare, Donna Kohlerschmidt, Lahari Das, Senamile L. Ngema +14 more

Brief Report: Differentiated Service Delivery Framework for People With Multidrug-Resistant Tuberculosis and HIV Coinfection

JAIDS Journal of Acquired Immune Deficiency Syndromes(2024)10.1097/qai.0000000000003394

N/A

0DataRank · unranked

3 citations

Allison Wolf, Rubeshan Perumal, Boitumelo Seepamore, Kevin Guzman, Jesse Ross +10 more

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00092-3

N/A

0DataRank · unranked

310 citations

Tahlia Perumal, Harry Moultrie, Rubeshan Perumal, Aliasgar Esmail, Alex Scott +16 more

A position statement and practical guide to the use of particulate filtering facepiece respirators (N95, FFP2, or equivalent) for South African health workers exposed to respiratory pathogens including Mycobacterium tuberculosis and SARS-CoV-2

African Journal of Thoracic and Critical Care Medicine(2021)10.7196/ajtccm.2021.v27i4.173

N/A

0DataRank · unranked

7 citations

Salome Charalambous, Aaron S Karat, A Von Delf, Umesh Lalloo, Richard N. van Zyl-Smit +26 more